The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2014Retinal Pathology in Parkinson’s Disease: Implications for Vision and Biomarkers
Study Rationale:
Vision problems are not what most of us think of when we think of Parkinson’s disease (PD), but there are some physical changes in the retina of people with PD... -
Research Grant, 2014Development of a Biomarker Assay for Oxidized DJ-1 in Parkinson’s Disease
Study Rationale:
Mutations in the DJ-1 gene cause an early-onset form of Parkinson’s disease (PD). The DJ-1 protein is an attractive biomarker for sporadic PD, as well, since it is... -
Research Grant, 2014Role of Phosphodiesterase 10A in Early Sporadic Parkinson’s Disease
Study Rationale:
We have collected preliminary data from people who were recently diagnosed with Parkinson's disease (PD), which show that an enzyme called phosphodiesterase 10A (PDE... -
LRRK2 LEAPS, 2014Link between LRRK2, Alpha-synuclein and Lysosomal Function
Study Rationale:
Our goal is to test whether Parkinson’s disease (PD) patients carrying a LRRK2 mutation have an abnormality in their lysosomes, a part of a cell that is necessary for degrading waste... -
Alpha-synuclein Pathology, 2014Contrasting Pathological Versus Normal Alpha-synuclein Assemblies
Study Rationale:
Parkinson’s disease (PD) is characterized by Lewy bodies composed of the protein alpha-synuclein in dopamine-producing nerve cells. The protein aggregates are also... -
Alpha-synuclein Pathology, 2014Characterization and Validation of Disease-specific Alpha-synuclein Species
Study Rationale
Alpha-synuclein aggregates called Lewy bodies are the hallmark of Parkinson’s disease (PD). Methods to measure alpha-synuclein in cerebrospinal fluid do exist today. However, these...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.